Related Experiment Video
Updated: Mar 20, 2026
07:57
Assessing Whole-Body Lipid-Handling Capacity in Mice
Published on: November 24, 2020
4.9K
JCL roundtable: Lessons from genetic variants altering lipoprotein metabolism
William Virgil Brown1, Brian A Ference2, Sekar Kathiresan3
1Emory University School of Medicine, Atlanta, GA, USA.
Journal of Clinical Lipidology
|May 22, 2016
Summary
Genetic analysis reveals links between gene variants and diseases like atherosclerosis. Genome-wide association studies (GWAS) use large-scale data to understand disease mechanisms and risk factors.
Area of Science:
- Genetics and Genomics
- Cardiovascular Disease Epidemiology
- Molecular Biology
Background:
- The Human Genome Project's completion enabled genetic variant discovery.
- Advanced methodologies allow rapid analysis of genes and exomes.
- Genetic analysis is now a key tool in large-scale epidemiologic studies.
Purpose of the Study:
- To discuss genetic variants influencing lipoprotein concentrations.
- To explore associations between genetic variants and early-onset vascular disease.
- To highlight the role of genome-wide association studies (GWAS) in understanding disease.
Main Methods:
- Utilizing large-scale genetic analysis and epidemiologic tools.
- Examining gene structure variants and their correlation with phenotypic markers.
- Applying genome-wide association studies (GWAS) to atherosclerosis and its risk factors.
Main Results:
- GWAS have revealed insights into the mechanisms of various disorders.
- Genetic variants are linked to changes in lipoprotein concentrations.
- Specific genetic variants are associated with earlier onset of clinical vascular disease.
Conclusions:
- Genetic discoveries are advancing our understanding of disease etiology.
- Genome-wide association studies (GWAS) are powerful for identifying disease-related genetic variants.
- Research focuses on genetic contributions to atherosclerosis and vascular disease risk.
Related Concept Videos
01:29Pharmacogenetic Phenotypes: Alterations in Pharmacokinetics, Drug Targets and Biologic Milieu
102
Genetic variations significantly influence drug response through pharmacokinetics, receptor interactions, and biologic milieu modifications. Pharmacokinetic alterations impact drug metabolism and clearance, affecting efficacy and toxicity. Variants in drug-metabolizing enzymes, such as CYP2C9 and CYP2C19, alter drug activation and elimination. For example, CYP2C9 loss-of-function variants require lower warfarin doses to prevent excessive bleeding, while CYP2C19 variants reduce clopidogrel...
102
01:29Pharmacogenomics: Identification of New Drug Targets
75
Advances in genomics have profoundly influenced drug discovery by increasing both the speed and accuracy of pharmaceutical development. Pharmacogenomics, which examines how genetic variation influences drug response, facilitates the identification of novel therapeutic targets and enables patient stratification for personalized treatment. These strategies contribute to improved drug efficacy, minimized adverse effects, and more efficient clinical trial design.Mapping genetic differences...
75
01:27Principles of Pharmacogenetics: Types of Genetic Variants
86
The human genome is over 99.9% identical between individuals, yet genetic differences exist at millions of bases. The human genome contains approximately 3 million variant positions per individual, many of which are heterozygous, contributing to genetic diversity and individual traits. Genetic variations include single-nucleotide polymorphisms (SNPs), insertions, deletions, and copy number variations (CNVs).SNPs, the most common variation, involve single-base changes in DNA. These can be...
86
01:24Overview of Lipid Metabolism
6.5K
Lipid metabolism is a crucial process in the human body that involves the synthesis and degradation of lipids. This process is essential for energy production, cell membrane formation, and hormone production, among other functions.
Lipolysis: The Breakdown of Lipids:
Lipolysis is the process of breaking down lipids, particularly triglycerides, into glycerol and fatty acids. This process typically occurs in the adipose tissue and is triggered by various hormones, including glucagon and...
Lipolysis: The Breakdown of Lipids:
Lipolysis is the process of breaking down lipids, particularly triglycerides, into glycerol and fatty acids. This process typically occurs in the adipose tissue and is triggered by various hormones, including glucagon and...
6.5K
01:27Pharmacogenetics of Drug Metabolism: Overview
101
Genetic polymorphism in drug metabolism is crucial to the inter-individual variability observed in drug responses. Drug metabolism primarily involves the chemical modification of drugs and other xenobiotics to enhance their elimination by increasing their polarity. Two main classes of enzymes mediate this biotransformation process: Phase I enzymes, primarily cytochrome P450s, catalyze oxidation and reduction reactions, while other enzymes, such as esterases, mediate hydrolysis, and Phase II...
101
01:16Pharmacogenetics of Drug Transporters: P-Glycoprotein and Solute Carrier Transporters
104
The pharmacogenetics of drug transporters is increasingly recognized as a critical factor influencing interindividual variability in drug absorption, distribution, and elimination. These membrane-bound proteins regulate drugs' movement across cellular barriers by actively pumping them out (efflux) or facilitating their uptake (influx). Among the major transporter families, ATP-binding cassette (ABC) and solute carrier (SLC) transporters play particularly prominent roles. Genetic polymorphisms...
104